Shares of VOLC Down 38.4% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Fri Sep 05, 9:08AM CDT
SmarTrend identified a Downtrend for Volcano (NASDAQ:VOLC) on March 28th, 2014 at $19.60. In approximately 5 months, Volcano has returned 38.35% as of today's recent price of $12.08.
GTLS, XRT, HWCC, IHF, RZG, VOLC Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Thu Sep 04, 9:47AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Chart Industries Inc (NASDAQ:GTLS), SPDR S&P Retail ETF (NYSE:XRT), Houston Wire & Cable Co (NASDAQ:HWCC), Ishares Dow Jones US Healthcare Providers Index Fund (NYSE:IHF), Rydex S&P SmallCap 600 Pure Growth ETF (NYSE:RZG), Volcano Corp (NASDAQ:VOLC) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
Volcano Corporation Presentation At Morgan Stanley Conference To Be Webcast
PR Newswire - Tue Sep 02, 7:00AM CDT
Volcano Corporation (Nasdaq: VOLC), a leading company focused on improving patient and economic outcomes on a global basis by developing and delivering innovative minimally invasive coronary and peripheral visualization, physiology diagnostics and therapies, said today that it will be participating in the Morgan Stanley Healthcare conference on Tuesday, September 9.
Downtrend Call Working As Volcano Stock Falls 36.8% (VOLC)
Comtex SmarTrend(R) - Thu Aug 28, 4:46PM CDT
SmarTrend identified a Downtrend for Volcano (NASDAQ:VOLC) on March 28th, 2014 at $19.60. In approximately 5 months, Volcano has returned 36.82% as of today's recent price of $12.38.
vCom Solutions Signs New Clients, Finds Success With Mobility Management Solution
Marketwire - Mon Aug 25, 5:00AM CDT
vCom Solutions, a leading provider of fixed and mobile telecommunications management, recently signed several new clients in the financial services, legal, and manufacturing industries. vCom has been engaged to provide its professional services and leading cloud-based telecom management software platform to manage their wireline and mobility environments. These clients include Huf North America and North Valley Bank. Additionally, Volcano Corporation has added vCom's Mobility Lifecycle Management to the suite of services vCom already provides to them.
Volcano Has Returned 36.3% Since SmarTrend Recommendation (VOLC)
Comtex SmarTrend(R) - Thu Aug 14, 9:36AM CDT
SmarTrend identified a Downtrend for Volcano (NASDAQ:VOLC) on March 28th, 2014 at $19.60. In approximately 5 months, Volcano has returned 36.26% as of today's recent price of $12.49.
3 Stocks Rising on Unusual Volume
at The Street - Thu Aug 14, 6:00AM CDT
Often when above-average volume moves into an equity, it precedes a large spike in volatility.
Volcano Corporation (VOLC) in Focus: Stock Tanks 20.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Aug 11, 7:43AM CDT
Make sure to keep a close watch on Volcano Corporation the near future, and especially on earnings estimates following the recent slump.
Nasdaq stocks posting largest volume increases
AP - Fri Aug 08, 5:06PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
Nasdaq stocks posting largest percentage decreases
AP - Fri Aug 08, 5:06PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
Gap and Post Holdings are big market movers
AP - Fri Aug 08, 3:36PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:
Volcano (VOLC) Posts Strong Q2 Earnings, Guides Low for 2014 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 08, 11:00AM CDT
Volcano Corporation (VOLC) reported second-quarter 2014 adjusted earnings of a penny per share, substantially ahead of the Zacks Consensus Estimate of loss of 4 cents.
Why Volcano (VOLC) Stock Is Declining Today
at The Street - Fri Aug 08, 10:03AM CDT
Volcano (VOLC) shares are tanking after being downgraded to 'market perform' by analysts at Oppenheimer.
Downgrade Alert for Volcano (VOLC)
Comtex SmarTrend(R) - Fri Aug 08, 6:58AM CDT
Volcano (NASDAQ:VOLC) was downgraded from Outperform to Perform at Oppenheimer today. The stock closed yesterday at $15.78 on volume of 706,000 shares, above average daily volume of 565,000. Over the past year, Volcano has traded in a range of $15.38 to $24.62 and closed yesterday at $15.78, 3% above that low. In the last five trading sessions, the 50-day moving average (MA) has fallen 0.8% while the 200-day MA has slid 0.8%.
Volcano Reports Second Quarter Results
PR Newswire - Thu Aug 07, 3:05PM CDT
Volcano Corporation (Nasdaq: VOLC), a leading company focused on improving patient and economic outcomes on a global basis by developing and delivering innovative minimally invasive coronary and peripheral visualization, physiology diagnostics and therapies, today reported results for the second quarter and first six months of 2014.
Volcano Shares Down 16.7% Since SmarTrend's Sell Call (VOLC)
Comtex SmarTrend(R) - Thu Aug 07, 9:19AM CDT
SmarTrend identified a Downtrend for Volcano (NASDAQ:VOLC) on March 28th, 2014 at $19.60. In approximately 4 months, Volcano has returned 16.66% as of today's recent price of $16.33.
Volcano Corporation Presentation At Canaccord Genuity Conference To Be Webcast
PR Newswire - Tue Aug 05, 7:00AM CDT
Volcano Corporation (Nasdaq: VOLC), a leading company focused on improving patient and economic outcomes on a global basis by developing and delivering innovative minimally invasive coronary and peripheral visualization, physiology diagnostics and therapies, said today that it will be participating in the Canaccord Genuity Growth Conference on Wednesday, August 13.
Peripheral Vascular Devices - Global Trends, Estimates and Forecasts, 2012-2018
M2 - Tue Aug 05, 4:31AM CDT
Research and Markets (http://www.researchandmarkets.com/research/34vckj/peripheral) has announced the addition of the "Peripheral Vascular Devices - Global Trends, Estimates and Forecasts, 2012-2018" report to their offering. Global Peripheral Vascular Devices sector forecasts to reach US$5 billion by 2016 at a CAGR of 10.8% during the analysis period 2012-2018. North American region accounts for highest percentage approximately 42% (2015) of global share while Europe follows next with nearly 27.7% (2018) of the market. Asia-Pacific is the fastest growing region with a CAGR of 12.5% driving a market value of US$1 billion by 2015. On a global scale, projections for Peripheral Vascular Stents market value indicate nearly 36% by 2015 leaving the rest of the market to the Vascular Closure Devices, AAA Stent Grafts, Inferior Vena Cava (IVC) Filters)etc. Geographical analysis for Peripheral Guidewires market shows that the highest Compounded Annual Growth Rate (CAGR) of 13.8% is anticipated from Asia-Pacific region during the analysis period 2012-2018. Europe follows Asia-Pacific with a CAGR of 12.7% while the North America forecasts to drive with a growth rate of 10.8%. Companies Mentioned: - Abbott Vascular Devices - Abiomed, Inc. - Accellent, Inc. - Accutech, Llc - Advansource Biomaterials Corporation - Aerotel Medical Systems, Ltd. - Alere, Inc. - All Pro Corporation - Ambu A/S - Angiodynamics, Inc. - Aortech International, Plc. - Apc Cardiovascular, Ltd. - Aptus Endosystems, Inc. - Arterial Remodeling Technologiesuscome Limited - Asahi Intecc Co., Ltd. - Asahi Kasei Corporation - Ash Access Technology, Inc. - Asian Heart Institute - Atcor Medical Holdings Limited - Atricure, Inc. - Atrium Medical Corporation - Baxter International Inc. - Becton, Dickinson & Co. - Beijing Anzhen Hospital - Berlin Heart Gmbh - Bioclinica - Bioheart, Inc. - Biophan Technologies, Inc. - Biosense Webster, Inc. - Dr?ger Medical Ag & Co. Kg - Edwards Lifesciences, Llc. - Endologix Incorporated - Esaote S.P.A - Fleming Medical Limited - Fluxion - Fudan University Zhongshan Hospital - Fukuda Denshi Co., Ltd. - Gamida Cell Ltd. - Ge Healthcare - Goodman Co., Ltd. - Greatbatch, Inc. - Heartware Ltd. - Hospira, Inc. - Volcano Corporation - 3M Healthcare For more information visit http://www.researchandmarkets.com/research/34vckj/peripheral